Logo Logo
Hilfe
Hilfe
Switch Language to English

Bruggen, M-C.; Valencak, J.; Stranzenbach, R.; Li, N.; Stadler, R.; Jonak, C.; Bauer, W.; Porkert, S.; Blaschke, A.; Meiss, F.; Nicolay, J. P.; Wehkamp, U.; Schlaak, M.; Nguyen, V. A.; Romani, N.; Cozzio, A.; Gayathri, N.; Dimitriou, F.; French, L. E.; Dummer, R. und Guenova, E. (2020): Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study. In: Journal of the European Academy of Dermatology and Venereology, Bd. 34, Nr. 7: S. 1489-1495

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Background: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive type of haematologic precursor malignancy primarily often manifesting in the skin. We sought to provide a thorough clinical characterization and report our experience on therapeutic approaches toBPDCN. Methods In the present multicentric retrospective study, we collected allBPDCNcases occurring between 05/1999 and 03/2018 in 10 secondary care centres of the German-Swiss-Austrian cutaneous lymphoma working group. Results A total of 37BPDCNcases were identified and included. Almost 90% of the patients had systemic manifestations (bone marrow, lymph nodes, peripheral blood) in addition to skin involvement. The latter presented with various types of cutaneous lesions: nodular (in more than 2/3) and bruise-like (in 1/3) skin lesions, but also maculopapular exanthema (in circa 1/6). Therapeutically, 22 patients received diverse combinations of chemotherapeutic regimens and/or radiotherapy. Despite initial responses, all of them ultimately relapsed and died from progressive disease. Eleven patients underwent haematopoietic stem cell transplantation (HSCT;autologousHSCTn = 3, allo-HSCTn = 8). The mortality rate amongHSCTpatients was only 33.33% with a median survival time of 60.5 months. Conclusion Our study demonstrates the clinical diversity of cutaneousBPDCNmanifestations and the positive development observed after the introduction ofHSCT.

Dokument bearbeiten Dokument bearbeiten